Mediste Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.75 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.42 Cr
- Revenue Growth 96.10%
- Profit Growth 97.61%
- Ebitda 50.93%
- Net Worth 74.08%
- Total Assets 25.48%
About Mediste Pharmaceutical
Mediste Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 2017 (Seven years and seven months 2 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹4.42 Cr.
Shitiz Sukhija, Prem Madan, and Rohit Diwan serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999DL2017PTC320020
-
Company No.
320020
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jun 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mediste Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shitiz Sukhija
|
Director | 09-Jul-2018 | Current |
|
Prem Madan
|
Director | 30-Jun-2017 | Current |
|
Rohit Diwan
|
Director | 30-Jun-2017 | Current |
Financial Performance of Mediste Pharmaceutical.
Mediste Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.1% increase. The company also saw a substantial improvement in profitability, with a 97.61% increase in profit. The company's net worth Soared by an impressive increase of 74.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediste Pharmaceutical?
In 2022, Mediste Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medlix Hospitals And Healthcare LlpShitiz Sukhija is a mutual person
-
Millennium City Developers Private Limited
Shitiz Sukhija is a mutual person
-
Millennium Medicare Private Limited
Shitiz Sukhija is a mutual person
-
Millennium Medisolutions Private Limited
Shitiz Sukhija is a mutual person
Charges (Loans)
₹44.21 M
₹0
Charges Breakdown by Lending Institutions
- Others : 4.30 Cr
- Hdfc Bank Limited : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jan 2024 | Others | ₹4.30 Cr | Open |
| 19 Nov 2020 | Hdfc Bank Limited | ₹1.21 M | Open |
How Many Employees Work at Mediste Pharmaceutical?
Unlock and access historical data on people associated with Mediste Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediste Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediste Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.